News

Axonics® to Report Second Quarter 2022 Financial Results on August 1

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the…

2 years ago

IRLAB Expands Phase IIb/III PD-LIDs Study with Mesdopetam to Support Phase III Program and Expects Completion of Enrollment During the Summer

GOTHENBURG, SWEDEN / ACCESSWIRE / July 11, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) today announced that the…

2 years ago

Positive Initial Clinical Data from the B-LIEVE Dose-Confirmation Trial for FLT180a in Hemophilia B Presented at the International Society on Thrombosis and Haemostasis Congress

FLT180a generated protective FIX levels with no bleeding or need for FIX replacement The treatment was well tolerated with a…

2 years ago

OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Outset Medical, Inc. and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit…

2 years ago

MacroGenics Announces Closure of CP-MGA271-06 Study Evaluating Enoblituzumab plus Checkpoint Inhibition in Head and Neck Cancer

ROCKVILLE, MD, July 08, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative…

2 years ago

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Lille, France; Cambridge, MA; July 08, 2022 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving…

2 years ago

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., July 08, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and…

2 years ago

Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022

SEATTLE, July 08, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT)  a commercial-stage biotechnology company that aims to translate…

2 years ago

IL2M International Corp. Announces Merger with Aamani Healthcare Group

TORRANCE, July 08, 2022 (GLOBE NEWSWIRE) -- IL2M International Corp. (OTC: ILIM) a Healthcare Technology holding company, today announced a…

2 years ago

Veriheal Reminds Students About July 30 Innovation in Cannabis Scholarship Deadline

DENVER, CO / ACCESSWIRE / JULY 8, 2022 / Healthtech company Veriheal will soon be closing submissions for its third…

2 years ago